Michael Chermak
On January 23, 2023, Michael Chermak notified Cytta Corp (“CYTTA” or the Company) that he has resigned from all positions with the Company to pursue other interests and has no disagreements with management.
Highest-materiality recent filing
Cytta Corp. files 8-K/A to include former auditor Sadler's letter; content unknown
Amendment adds letter from Sadler, Gibb and Associates dated June 4, 2026 as Exhibit 16.1.
Cytta Corp. dismisses auditor Sadler Gibb before FY2025 audit completion, appoints RBSM LLP
Board dismissed Sadler, Gibb and Associates as independent auditor on May 28, 2026.
Cytta Corp. restates Dec 2024 financials; revenue overstated by $37K from unverified sales orders
Board concludes Dec 31, 2024 interim financials unreliable due to revenue recognition error.
Cytta Corp. to restate Dec 2024 10-Q revenue by $36,967 due to recognition error
Error of $36,976 in revenue recognition discovered by new auditors Sadler Gibb on July 7, 2025; restatement reduces revenue by $36,967.
Cytta Corp amends 8-K to include Prager Metis response letter dated July 1, 2025
Amendment No. 1 to Form 8-K adds Exhibit 16.1 — letter from former auditor Prager Metis CPAs, LLC dated July 1, 2025.
Cytta dismisses auditor Prager Metis over disputed fraudulent sales orders; appoints Sadler Gibb
Board dismissed Prager Metis CPAs on May 19, 2025 after it required an independent forensic review of third-party consultant sales orders recorded in Dec 31, 2024 quarterly.
Cytta Corp terminates agreement with Michael Elliott after fraudulent sales orders
Michael Elliott provided 33 fraudulent Law Enforcement Sales Orders using AI-generated fake confirmations.
Cytta Corp CAO Michael Chermak resigns to focus on Reticulate Micro as Executive Chairman
Michael Chermak resigned as Chief Administrative Officer and from all positions effective January 23, 2023.
Cytta furnishes investor presentation for June 8 conference; no specific details available
Company to attend investor conference on June 8, 2022; presentation furnished as Exhibit 99.1.
Cytta Corp. raises $2.96M via Series F Preferred Stock, trading approved on OTCQB
Sold 59.27M Series F Preferred shares at $0.05/share for total proceeds of $2,963,500.
On January 23, 2023, Michael Chermak notified Cytta Corp (“CYTTA” or the Company) that he has resigned from all positions with the Company to pursue other interests and has no disagreements with management.
Max materiality 0.90 · Median 0.57 · Most common event other_material